The only lytic delivered as a 5-second IV bolus for the treatment of acute myocardial infarction (AMI), TNKase ® (Tenecteplase) enables you to intervene quickly.
Tenecteplase increases your risk of bleeding, which can be severe or life-threatening. Call your doctor or seek emergency medical attention if you have bleeding that ...
Tenecteplase (trade name TNKase) is an enzyme used as a thrombolytic drug. Tenecteplase is a tissue plasminogen activator (tPA) produced by recombinant DNA technology ...
Learn about the prescription medication Tnkase (Tenecteplase), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Tenecteplase is in a group of drugs called tissue plasminogen activators (TPAs). It works by helping your body produce a substance that dissolves unwanted blood clots.
tenecteplase [tĕ-nek´tĕ-plās] a modified form of human tissue plasminogen activator produced by recombinant DNA technology; used as a thrombolytic agent in the ...
Tenecteplase (TNKase™): A Clinical Review . Volume IV, Number 1 | January/February 2001 Michael Militello, Pharm.D., BCPS
Dosage. TNKase® (Tenecteplase) is for intravenous administration only. The recommended total dose should not exceed 50 mg and is based upon patient weight.
What it Treats TNKase ® (Tenecteplase) is a single-bolus thrombolytic, or clot-busting agent, approved by the U.S. Food and Drug Administration for use in mortality ...
TNKase® (Tenecteplase) DESCRIPTION TNKase® (Tenecteplase) is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established ...